End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,410 KRW | -0.16% | +0.49% | -3.57% |
2023 | JW Lifescience Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | JW Lifescience Corporation(KOSE:A234080) dropped from S&P Global BMI Index | CI |
Sales 2022 | 189B 139M 11.57B | Sales 2023 | 207B 152M 12.66B | Capitalization | 199B 146M 12.2B |
---|---|---|---|---|---|
Net income 2022 | 14.96B 10.98M 916M | Net income 2023 | 28.14B 20.66M 1.72B | EV / Sales 2022 | 1.2 x |
Net Debt 2022 | 38.32B 28.13M 2.35B | Net Debt 2023 | 17.97B 13.19M 1.1B | EV / Sales 2023 | 1.05 x |
P/E ratio 2022 |
12.6
x | P/E ratio 2023 |
7.08
x | Employees | 256 |
Yield 2022 |
4.12% | Yield 2023 |
3.89% | Free-Float | 54.08% |
1 day | -0.16% | ||
1 week | +0.49% | ||
Current month | -0.32% | ||
1 month | -0.64% | ||
3 months | -0.64% | ||
6 months | -2.90% | ||
Current year | -3.57% |
Managers | Title | Age | Since |
---|---|---|---|
Seong-Nam Cha
CEO | Chief Executive Officer | 67 | - |
Jung-Yeol Noh
BRD | Director/Board Member | 57 | - |
Cheol-Won Park
AUD | Comptroller/Controller/Auditor | 80 | 17/17/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hyeon-Soon Lee
BRD | Director/Board Member | 73 | - |
Seong-Nam Cha
CEO | Chief Executive Officer | 67 | - |
Jung-Yeol Noh
BRD | Director/Board Member | 57 | - |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 12,410 | -0.16% | 5,592 |
02/24/02 | 12,430 | -0.16% | 18,330 |
30/24/30 | 12,450 | -0.56% | 23,438 |
29/24/29 | 12,520 | +1.38% | 21,701 |
26/24/26 | 12,350 | +0.65% | 8,259 |
End-of-day quote Korea S.E., May 03, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.57% | 142M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- A234080 Stock